ストックスクリーナーアプリを入手
11.10
5.41%
0.57
アフターアワーズ：
11.10
前日終値:
$10.53
開ける：
$10.45
24時間の取引高:
39,773
Relative Volume:
0.57
時価総額：
$288.62M
収益：
$26.00M
当期純損益:
$-219.71M
株価収益率:
-0.2229
EPS:
-49.8
ネットキャッシュフロー:
$-51.37M
1週間 パフォーマンス:
-11.06%
1か月 パフォーマンス:
-16.67%
6か月 パフォーマンス:
-40.06%
1年 パフォーマンス:
-16.98%
1日の値動き範囲:
$10.36
$11.24
1週間の範囲:
$10.13
$12.57
52週間の値動き範囲:
$8.46
$26.50
Cartesian Therapeutics Inc Stock (RNAC) Company Profile
名前
Cartesian Therapeutics Inc
セクター
電話
301-348-8698
住所
7495 NEW HORIZON WAY, FREDERICK
RNAC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RNAC
Cartesian Therapeutics Inc
|
11.10 | 273.30M | 26.00M | -219.71M | -51.37M | -49.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-09 | 開始されました | Wedbush | Outperform |
| 2024-12-19 | 開始されました | BTIG Research | Buy |
| 2024-08-06 | 開始されました | TD Cowen | Buy |
| 2024-07-02 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-04 | 開始されました | Oppenheimer | Outperform |
| 2024-05-24 | 開始されました | Mizuho | Buy |
| 2024-04-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-04-23 | 開始されました | Leerink Partners | Outperform |
| 2023-08-18 | ダウングレード | SVB Securities | Outperform → Market Perform |
| 2022-06-14 | 繰り返されました | Needham | Buy |
| 2022-06-06 | 開始されました | SVB Leerink | Outperform |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-01-26 | アップグレード | Mizuho | Neutral → Buy |
| 2020-10-01 | ダウングレード | Mizuho | Buy → Neutral |
| 2020-10-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2020-06-12 | ダウングレード | Stifel | Buy → Hold |
| 2020-04-28 | 開始されました | H.C. Wainwright | Buy |
| 2020-01-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-01-21 | 開始されました | William Blair | Outperform |
| 2018-06-27 | 開始されました | Janney | Buy |
| 2017-03-30 | 繰り返されました | UBS | Buy |
すべてを表示
Cartesian Therapeutics Inc (RNAC) 最新ニュース
Real time alert setup for Cartesian Therapeutics Inc. performanceFree Price Action Based Buy Opportunity List - Newser
Relative strength of Cartesian Therapeutics Inc. in sector analysisFree Market Momentum and Signal Alerts - Newser
Multi factor analysis applied to Cartesian Therapeutics Inc.Free AI Based High Gain Watchlist Scanner - Newser
Cartesian Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cartesian Therapeutics 2025 Q2 Earnings Strong Net Income Amid Revenue Decline - AInvest
Cartesian Therapeutics Reports Positive Q2 2025 Earnings - TipRanks
Cartesian Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Cartesian Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cartesian (RNAC) Q2 Revenue Drops 99% - sharewise.com
Cartesian Therapeutics reports second quarter 2025 financial results and provides business update - MarketScreener
Cartesian Therapeutics Inc Reports Q2 2025 EPS of $0.51, Surpassing Estimates, with Revenue at $298,000 - GuruFocus
Cartesian Therapeutics, Inc. SEC 10-Q Report - TradingView
Design Therapeutics, Inc. shares rise 1.26% intraday as Cartesian Therapeutics reports strong clinical trial progress and global expansion. - AInvest
Cartesian Therapeutics Announces New Employment Inducement Grants - The Globe and Mail
Cartesian Therapeutics Grants Inducement Awards to New Employees. - AInvest
Cartesian Therapeutics Announces New Employee Incentive Grants - AInvest
Cartesian Therapeutics Expands Leadership Team with Strategic Stock Options Worth $71,760 - Stock Titan
Zacks.com featured highlights Amazon.com, Alphabet and Meta Platforms - The Globe and Mail
Candlestick Signal Suggests Reversal in Cartesian Therapeutics Inc.Expert Verified Stock Trade Ideas Backed by Data - metal.it
Cartesian Therapeutics Inc. Stock Analysis and ForecastBuild wealth faster with disciplined trading - Jammu Links News
Does Cartesian Therapeutics Inc. stock perform well during market downturnsMaximize returns with smart investment plans - Jammu Links News
What institutional investors are buying Cartesian Therapeutics Inc. stockUnlock powerful investment tools for free - Jammu Links News
What catalysts could drive Cartesian Therapeutics Inc. stock higher in 2025Get timely alerts on top-performing stocks - Jammu Links News
What makes Cartesian Therapeutics Inc. stock price move sharplyHarness the power of proven investment plans - Jammu Links News
When is Cartesian Therapeutics Inc. stock expected to show significant growthCapitalize on market shifts before others do - Jammu Links News
Is Cartesian Therapeutics Inc. stock overvalued or undervaluedExceptional trading results - Jammu Links News
Can momentum traders help lift Cartesian Therapeutics Inc.Predictive Short-Term Market Reversal Alerts - Newser
What are the technical indicators suggesting about Cartesian Therapeutics Inc.Free Stock Forecasts For 2025 - Jammu Links News
Chart overlay techniques for tracking Cartesian Therapeutics Inc.Free Alert Feed for Momentum Based Picks - Newser
How to integrate Cartesian Therapeutics Inc. into portfolio analysis toolsRisk-Managed Trade Alerts for Consistency - Newser
Price action breakdown for Cartesian Therapeutics Inc.Free Fast Entry High Potential Stock Alerts - Newser
Progressive Investment Management Corp Reduces Amazon Holdings - The Globe and Mail
How many analysts rate Cartesian Therapeutics Inc. as a “Buy”Free Stock Target Finder With Proven Results - Jammu Links News
Technical signs of recovery in Cartesian Therapeutics Inc.Fast Return Equity Forecast With Logic - Newser
How Cartesian Therapeutics Inc. stock performs during market volatilityFree Optimized Watchlist With Daily Adjustments - Newser
Myasthenia Gravis Market Growth to Accelerate in Forecast - openPR.com
Cartesian Therapeutics Inc. Moves Into Overbought Range Analysts CautiousBuy Alerts With Low Risk Confirmation Noted - metal.it
Why Cartesian Therapeutics Inc. stock attracts strong analyst attentionAlpha Stock Picks with Chart Confirmation - Newser
How to use a screener to detect Cartesian Therapeutics Inc. breakoutsPortfolio Building Plan and Summary Guide - Newser
New Product Launches: Will They Boost Cartesian Therapeutics Inc. Stock in 2025Entry and Exit Strategy Optimizer Tool Tested - metal.it
Risk vs reward if holding onto Cartesian Therapeutics Inc.Free Momentum Based Equity Trading Plan - Newser
Screener Results Flag Cartesian Therapeutics Inc. as OversoldSecure Return Focused Investment Plan Released - metal.it
How strong is Cartesian Therapeutics Inc. company’s balance sheetSmart Portfolio Ideas For Fast Growth - Jammu Links News
Published on: 2025-07-28 21:34:06 - beatles.ru
Cartesian Therapeutics Inc (RNAC) 財務データ
収益
当期純利益
現金流量
EPS
1.02%
3.70%
大文字化:
|
ボリューム (24 時間):